Europska Unija - poljski - EMA (European Medicines Agency)

pfizer europe ma eeig  - abrocitinib - zapalenie skóry, atopowe - inne preparaty dermatologiczne - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

Europska Unija - poljski - EMA (European Medicines Agency)

pfizer europe ma eeig - somatrogon - growth and development - przysadka i podwzgÓrze hormony i odpowiedniki - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Europska Unija - poljski - EMA (European Medicines Agency)

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - infekcje pneumokokowe - szczepionki - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. zobacz rozdziały 4. 4 i 5. 1 w celu uzyskania informacji na temat ochrony przed określonymi serotypami pneumokokowymi. apexxnar should be used in accordance with official recommendations. .

Europska Unija - poljski - EMA (European Medicines Agency)

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - infekcje wirusem oddechowym - szczepionki - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. zobacz rozdziały 4. 2 i 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. stosowanie tej szczepionki powinno odbywać się zgodnie z oficjalnymi zaleceniami.

Europska Unija - poljski - EMA (European Medicines Agency)

pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - leki immunosupresyjne - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.